Class Action Update - Claim Your Cash (December, 2019)
Irbesartan, Losartan and Valsartan (Azido Impurity) Class Action - Rice Harbut Elliott
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel
Actavis, Teva, Mylan Face Pravastatin Price-Fixing Class Action Lawsuit - Top Class Actions
Tentative $161.5 million settlement reached in opioid trial
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
Purdue Pharma, others could deduct opioid settlements from taxes
Teva reaches $925,000 settlement to resolve drug price-fixing claims - PMLiVE
$24M Class Action Settlement Reached with Teva Over Nexium Pay-for-Delay - Top Class Actions
Teva to pay $512M to resolve Provigil-delay lawsuit
Teva settles investor lawsuit for $420m - Globes
Teva Pharmaceuticals Retirement Savings Plan $2.55M Class Action Settlement - Top Class Actions
Teva enters opioid settlement agreement with US state Rhode Island
💲420,000,000.00 Class Action Settlement | Deadline TEVA Stock News Money Stocks $TEVA Pharmaceutical - YouTube
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva to pay $54M to settle whistleblower lawsuit - Philadelphia Business Journal
Teva to be First Target in Generic Price-Fixing Suit – Policy & Medicine
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ONTARIO TEACHERS' PENSION PLAN BOARD, Individually and as Lead Plaintiff
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Shareholder Notice
Teva Stock: Legal Risks Offer Setup For A Strangle Or Straddle (NYSE:TEVA) | Seeking Alpha
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva settles investor lawsuit for $420m - Globes
Teva is primed for a big bounce after years of underperformance, Barclays says
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
